168 related articles for article (PubMed ID: 36343537)
21. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
Saha M; Bali A; Patra SR; Singh J
Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
[TBL] [Abstract][Full Text] [Related]
24. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
[TBL] [Abstract][Full Text] [Related]
25. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
Prajapati KJ; Kothari CS
Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
Adhikari S; Tian J; Rustum AM
J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
[TBL] [Abstract][Full Text] [Related]
28. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
[TBL] [Abstract][Full Text] [Related]
29. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
Shekhar S; Bali A
Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
[TBL] [Abstract][Full Text] [Related]
30. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
Salunke N; Kharkar PS; Pandita N
Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
[TBL] [Abstract][Full Text] [Related]
31. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
Adhikari S; Rustum AM
J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
[TBL] [Abstract][Full Text] [Related]
33. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
[TBL] [Abstract][Full Text] [Related]
35. Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR.
Adhikari S; Rustum AM
J Pharm Biomed Anal; 2022 Aug; 217():114862. PubMed ID: 35662014
[TBL] [Abstract][Full Text] [Related]
36. Study on the hydrolytic degradation behaviour of bictegravir by LC-PDA-Q/TOF-MS/MS NMR and in silico toxicity assessment.
Dannarm SR; Harini D; Reddy GN; Ali N; Sonti R
J Pharm Biomed Anal; 2024 Feb; 239():115909. PubMed ID: 38104374
[TBL] [Abstract][Full Text] [Related]
37. Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance.
Tidke M; Golla VM; Kushwah BS; Naik DD; Gananadhamu S
Biomed Chromatogr; 2023 Aug; 37(8):e5636. PubMed ID: 37005769
[TBL] [Abstract][Full Text] [Related]
38. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
39. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
[TBL] [Abstract][Full Text] [Related]
40. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
